Raft platforms highly enriched in cholesterol: major scaffolds for IL-6 signalling assembly with implications in inflammation and cancer

FEBS J. 2022 Oct;289(19):5891-5894. doi: 10.1111/febs.16547. Epub 2022 Jun 21.

Abstract

Interleukin-6 (IL-6) is a pleiotropic cytokine with complex and major roles in inflammation, which could be linked to the different ways IL-6 signals at the plasma membrane. In this issue of FEBS Journal, Woo and co-workers present evidence for the involvement of Eps15 homology domain-containing protein 1 (EHD1)-mediated lipid raft platforms, highly enriched in cholesterol, in the IL-6 signalling pathway. Because of the strong connection between IL-6, inflammation and cancer, one implication of this report is that agents or approaches targeting cholesterol-rich raft platforms may assist the development of novel strategies to treat inflammatory and malignant diseases. Comment on: https://doi.org/10.1111/febs.16458.

Keywords: cancer; cell signalling; cholesterol; cholesterol-rich raft platforms; inflammation; interleukin-6; lipid raft; therapeutic target.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cholesterol / metabolism
  • Cytokines / metabolism
  • Humans
  • Inflammation / metabolism
  • Interleukin-6* / genetics
  • Interleukin-6* / metabolism
  • Membrane Microdomains / metabolism
  • Neoplasms* / pathology
  • Vesicular Transport Proteins / metabolism

Substances

  • Cytokines
  • EHD1 protein, human
  • Interleukin-6
  • Vesicular Transport Proteins
  • Cholesterol